PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A self-emulsifying hydrogel formulation (250 mg/d) significantly improved symptoms of early satiety, bloating, and heartburn [PMID:41054174].
Studied in a double-blind randomized trial comparing 1g daily of Asafoetida against oral contraceptives [PMID:39086865].
Aqueous extract reduced cardiovascular parameters in angiotensin II-induced acute hypertension in rats [PMID:33912493].
Demonstrated antinociceptive effects in mice using hot plate and acetic acid induced writhing tests [PMID:25657791].
Powder and oil extracts decreased counts and viability of isolates in vitro [PMID:22584378].
Safety & adverse effects
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 31629871 (2019) — NMR-based metabolomic study of asafoetida. · Fitoterapia
- 2.PMID: 28725631 (2017) — Biological activities and medicinal properties of Asafoetida: A review. · Journal of traditional and complementary medicine
- 3.PMID: 33456735 (2020) — Preventive Effect of Ferula asafoetida Oleo Gum Resin on Histopathology in Cuprizone-Induced Demyelination Mice. · International journal of preventive medicine
- 4.PMID: 41054174 (2025) — Ferula asafoetida oleo-gum resin alleviates dyspepsia symptoms through modulation of microbiome-gut-brain axis: A randomized, double-blind, placebo-controlled study. · Medicine
- 5.PMID: 40573306 (2025) — Ferulic Acid as an Anti-Inflammatory Agent: Insights into Molecular Mechanisms, Pharmacokinetics and Applications.